WeVote
Log In

Bill

Bill

AB 1843

Communicable diseases: hepatitis C.

2025-2026 Regular Session Introduced by Sade Elhawary

AB 1843 establishes hepatitis B and C communicable disease protocols in California, potentially requiring expanded testing, provider reporting, and public health response measures.

In committee: Hearing postponed by committee.
#communicablediseases #hepatitisc
0
WeVote Research Nonpartisan
Bill Summary · AB 1843

Legislative bill overview

AB 1843 addresses hepatitis B and C as communicable diseases in California, likely establishing reporting requirements, testing protocols, or public health response procedures. The bill has undergone amendments in committee and is currently being reviewed by the Health Committee after being referred to multiple committees including Health, Public and Consumer Protection, and Judiciary.

Why is this important

Hepatitis B and C affect hundreds of thousands of Californians and can cause serious liver disease, cirrhosis, and cancer if left untreated. Clarifying disease classification and state response mechanisms can improve early detection, treatment access, and prevention efforts while potentially reducing healthcare costs and mortality.

Potential points of contention

  • Provider burden: Expanded reporting or testing mandates could increase administrative costs and clinical workload on healthcare providers, particularly in under-resourced settings
  • Privacy concerns: Enhanced disease surveillance and reporting requirements may raise questions about patient confidentiality and data security
  • Scope of requirements: Disagreement may emerge over which populations require testing, whether testing is mandatory or voluntary, and what resources the state will allocate to support implementation

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.